The effects of PPAR-γ inhibition on gene expression and the progression of induced osteogenic differentiation of human mesenchymal stem cells

Connective Tissue Research

Volumn 55, Issue 4, 2014, Pages 262-274

  Granéli, Cecilia ^a,b   Karlsson, Camilla ^a,b   Brisby, Helena ^a,b   Lindahl, Anders ^a,b   Thomsen, Peter ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BIOMATCELL   (Sweden)

Author keywords

Adipogenic differentiation; Leptin; Mesenchymal stem cells; Osteogenic differentiation; PPAR

Indexed keywords

ABC TRANSPORTER A1; ACETYL COENZYME A ACETYLTRANSFERASE 2; ADAM PROTEIN; ADAM19 PROTEIN; ADRENOMEDULLIN; ALCOHOL DEHYDROGENASE 1B; ALKALINE PHOSPHATASE; APOLIPOPROTEIN; BONE SIALOPROTEIN; CALCINEURIN; CALCIUM CHANNEL; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE IA; COLLAGEN TYPE 10; COLLAGENASE 3; CYTOCHROME P450; DEATH ASSOCIATED PROTEIN KINASE; DIMETHYLANILINE MONOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID BINDING PROTEIN 4; GROWTH DIFFERENTIATION FACTOR 5; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE 1; KRUPPEL LIKE FACTOR 15; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 4; RING FINGER PROTEIN 144B; THROMBOSPONDIN; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 10; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; OPEN READING FRAME; OSTEOGENIC DIFFERENTIATION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CLINICAL TRIAL; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST;

ADIPOGENESIS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; PPAR GAMMA;

EID: 84903751773     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2014.910198     Document Type: Article

References (44)

1. Huang W, Yang S, Shao J, Li Y-P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 2007;12:3068-92.
2. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7:885-96. (Pubitemid 44871415)
3. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289-312.
4. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells-biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007;9:204.
5. Schilling T, Nöth U, Klein-Hitpass L, Jakob F, Schutze N. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol 2007;271:1-17. (Pubitemid 46803047)
6. Lecka-Czernik B, Moerman E, Grant D, Lehmann J, Manolagas S, Jilka R. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002;143:2376-84. (Pubitemid 34521584)
7. Shockley KR, Lazarenko OP, Czernik PJ, Rosen CJ, Churchill GA, Lecka-Czernik B. PPARg2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 2009;106:232-46.
8. Rosen E, Sarraf P, Troy A, Bradwin G, Moore K, Milstone D, Spiegelman BM, Mortensen RM. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999; 4:611-17. (Pubitemid 29531140)
9. Yu W-H, Li F-G, Chen X-Y, Li J-T, Wu Y-H, Huang L-H, Wang Z, Li P, Wang T, Lahn BT, Xiang AP. PPARg suppression inhibits adipogenesis but does not promote osteogenesis of human mesen-chymal stem cells. Int J Biochem Cell Biol 2012;44:377-84.
10. Hong J-H, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005;309: 1074-8. (Pubitemid 41134465)
11. He J, Zhang J-F, Yi C, Lv Q, Xie W-D, Li J-N, Wan G, Cui K, Kung HF, Yang J, Yang BB, Zhang Y. miRNA-mediated functional changes through co-regulating function related genes. PLoS One 2010;5:e13558.
12. Zhang J-F, Fu W-M, He M-L, Xie W-D, Lv Q, Wan G, Li G, Wang H, Lu G, Hu X, Jiang S, Li JN, Lin MC, Zhang YO, Kung HF. MiRNA-20a promotes osteogenic differentiation of human mesen-chymal stem cells by co-regulating BMP signaling. RNA Biol 2011;8:829-38.
13. Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010;28:357-64.
14. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C, Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 2010;5:e11803.
15. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002;41:6640-50. (Pubitemid 34547354)
16. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, Conesa A, Tárraga J, Pascual-Montano A, Nogales-Cadenas R, Santoyo J, García F, Marbà M, Montaner D, Dopazo J. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010;38:W210-13.
17. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
18. Krause U, Harris S, Green A, Ylostalo J, Zeitouni S, Lee N, Gregory CA. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci USA 2010;107:4147-52.
19. David V, Martin A, Lafage-Proust M-H, Malaval L, Peyroche S, Jones DB, Vico L, Guignandon A. Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology 2007;148:2553-62. (Pubitemid 47007541)
20. MacArthur BD, Tare RS, Murawski K, Oreffo ROC. Identification of candidate regulators of multipotency in human skeletal progenitor cells. Biochem Biophys Res Commun 2008;377:68-72.
21. Rehn AP, Birch MA, Karlstrom E, Wendel M, Lind T. ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone 2007;41:231-8. (Pubitemid 47001821)
22. Hu L, Jonsson KB, Andersen H, Edenro A, Bohlooly-Y M, Melhus H, Lind T. Over-expression of Adamts1 in mice alters bone mineral density. J Bone Mine Metab 2012;30:304-11.
23. Cheng X, Yang T, Meng W, Liu H, Zhang T, Shi R. Overexpression of GDF5 through an adenovirus vector stimulates osteogenesis of human mesenchymal stem cells in vitro and in vivo. Cells Tissues Organs (Print). 2012;196:56-67.
24. Cornish J, Callon KE, Coy DH, Jiang N-Y, Xiao L, Cooper GJS, Reid IR. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am J Physiol Endocrinol Metab 1997; 273:E1113-20.
25. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H. NFAT and Osterix cooperatively regulate bone formation. Nat Med 2005;11:880-5. (Pubitemid 41161121)
26. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 2006;10:771-82. (Pubitemid 43779111)
27. Bassett JHD, Logan JG, Boyde A, Cheung MS, Evans H, Croucher P, Sun XY, Xu S, Murata Y, Williams GR. Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast function. Endocrinology 2012;153:3537-48.
28. Mori T, Sakaue H, Iguchi H, Gomi H, Okada Y, Takashima Y, Nakamura K, Nakamura T, Yamauchi T, Kubota N, Kadowaki T, Matsuki Y, Ogawa W, Hiramatsu R, Kasuga M. Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005;280:12867-75.
29. Hasegawa R, Tomaru Y, de Hoon M, Suzuki H, Hayashizaki Y, Shin JW. Identification of ZNF395 as a novel modulator of adipogenesis. Exp Cell Res 2013;319:68-76.
30. Charoenpanich A. Microarray analysis of human adipose-derived adult stem cells undergoing osteogenic differentiation in the presence and absence of 10% uniaxial cyclic tensile strain. Tissue Eng Part A 2011;17:2615-27.
31. Morikawa S, Murakami T, Yamazaki H, Izumi A, Saito Y, Hamakubo T, Kodama T. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J Atheroscler Thromb 2005;12:121-31.
32. Iida KT, Kawakami Y, Suzuki H, Sone H, Shimano H, Toyoshima H, Okuda Y, Yamada N. PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages. FEBS Lett 2002;520:177-81. (Pubitemid 34607296)
33. Zhu F, Friedman MS, Luo W, Woolf P, Hankenson KD. The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J Cell Physiol 2012;227:2677-85.
34. Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nature Publishing Group. Nat Rev Rheumatol 2011;7:43-9.
35. Hayami T, Kapila YL, Kapila S. MMP-1 (collagenase-1) and MMP-13 (collagenase-3) differentially regulate markers of osteo-blastic differentiation in osteogenic cells. Matrix Biol 2008;27: 682-92.
36. Lu W, Kim K-A, Liu J, Abo A, Feng X, Cao X, Li Y. R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression. FEBS Lett 2008;582:643-50.
37. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzmán M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276:25096-100.
38. Zeitouni S, Krause U, Clough BH, Halderman H, Falster A, Blalock DT, Chaput CD, Sampson HW, Gregory CA. Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Sci Transl Med 2012;4:132ra55.
39. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002;85: 825-36. (Pubitemid 34462792)
40. Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Miner Res 2002;17:1563-9.
41. Chang Y-J, Shih DT-B, Tseng C-P, Hsieh T-B, Lee D-C, Hwang SM. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006;24:679-85. (Pubitemid 44464772)
42. Han G, Jing Y, Zhang Y, Yue Z, Hu X, Wang L, Liang J, Liu J. Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin. Regul Pept 2010;163: 107-12.
43. Hess R, Pino A, Rios S, Fernandez M, Rodriguez J. High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J Cell Biochem 2005;94:50-7. (Pubitemid 41420323)
44. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001;16:1426-33. (Pubitemid 32675194)